Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study

LGEM Razenberg; YRBM van Gestel; Valery Lemmens; IHJT de Hingh; GJ Creemers

doi:10.1016/j.clcc.2015.12.006

Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study

LGEM Razenberg
, YRBM van Gestel
, Valery Lemmens
, IHJT de Hingh
, GJ Creemers

Public Health

Research output: Contribution to journal › Article › Academic › peer-review

34 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E41-E46
Journal	Clinical Colorectal Cancer
Volume	15
Issue number	2
DOIs	https://doi.org/10.1016/j.clcc.2015.12.006
Publication status	Published - 2016

Research programs

EMC NIHES-02-65-02

Access to Document

10.1016/j.clcc.2015.12.006

http://hdl.handle.net/1765/81274

Cite this

@article{c1a12ca8b56e417689ab0f5c2f951bf9,

title = "Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study",

author = "LGEM Razenberg and \{van Gestel\}, YRBM and Valery Lemmens and \{de Hingh\}, IHJT and GJ Creemers",

year = "2016",

doi = "10.1016/j.clcc.2015.12.006",

language = "Undefined/Unknown",

volume = "15",

pages = "E41--E46",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study

AU - Razenberg, LGEM

AU - van Gestel, YRBM

AU - Lemmens, Valery

AU - de Hingh, IHJT

AU - Creemers, GJ

PY - 2016

Y1 - 2016

U2 - 10.1016/j.clcc.2015.12.006

DO - 10.1016/j.clcc.2015.12.006

M3 - Article

C2 - 26762572

SN - 1533-0028

VL - 15

SP - E41-E46

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

IS - 2

ER -